J Korean Med Assoc.  2006 Nov;49(11):1046-1053. 10.5124/jkma.2006.49.11.1046.

Pharmacologic Treatment of Atopic Dermatitis

• Park CW

• KMID: 2184730
• DOI: http://doi.org/10.5124/jkma.2006.49.11.1046

Abstract

Atopic dermatitis (AD) is a chronic inflammatory pruritic skin disease that affects a large number of children and adults in Korea. The treatment of AD requires a comprehensive approach that includes evaluation of potential triggers and education of the patients and family members regarding proper avoidance measures. Because existing remedies for AD do not cure the disorder itself, a program of disease control and management should be pursued. Topical corticosteroids are the effective and relatively safe therapy for patients with AD, but prolonged usage can result in skin atrophy and other side-effects. The topical calcineurin inhibitors such as pimecrolimus and tacrolimus allow a steroid-free, anti-inflammatory topical therapy of AD. Occasionally, however, children afflicted with severe AD require more intensive therapies (e.g., ultraviolet light exposure systemic corticosteroids, and cyclosporine) that need close monitoring. This review focuses on the current guidelines of managing AD regarding the efficacy and safety of several pharmacologic options. Management strategies discussed include topical corticosteroids, topical calcineurin inhibitors, antihistamines and anti-infectives. A management algorithm is also presented.

Keyword

Atopic dermatitis; Systemic treatment; Topical calcineurin inhibitor; Topical steroid; Topical treatment

MeSH Terms

Adrenal Cortex Hormones
Adult
Atrophy
Calcineurin
Child
Dermatitis, Atopic*
Education
Histamine Antagonists
Humans
Korea
Skin
Skin Diseases
Tacrolimus
Ultraviolet Rays
Adrenal Cortex Hormones
Calcineurin
Histamine Antagonists
Tacrolimus

Figure

• 

  Figure 1 Algorithm for treatment of atopic dermatitis

Reference

1. Boguniewicz M, Schmid-Grendelmeier P, Leung DY. Atopic dermatitis. J Allergy Clin Immunol. 2006. 118:40–43.

2. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRAC TALL Consensus Report. J Allergy Clin Immunol. 2006. 118:152–169.

3. Abramovits W. A clinician's paradigm in the treatment of atopic dermatitis. J Am Acad Dermatol. 2005. 53:Suppl 1. S70–S77.

4. Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, et al. ICCAD II Faculty. (ICCAD II^*): International Consensus Conference on Atopic Dermatitis II (ICCAD II^*): clinical update and current treatment strategies. Br J Dermatol. 2003. 148:Suppl 63. 3–10.

5. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005. 352:2314–2324.